{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "26752192", "DateCompleted": {"Year": "2016", "Month": "07", "Day": "15"}, "DateRevised": {"Year": "2022", "Month": "01", "Day": "29"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2016", "Month": "01", "Day": "11"}], "ELocationID": ["e0146102", "10.1371/journal.pone.0146102"], "Journal": {"ISSN": "1932-6203", "JournalIssue": {"Volume": "11", "Issue": "1", "PubDate": {"Year": "2016"}}, "Title": "PloS one", "ISOAbbreviation": "PLoS One"}, "ArticleTitle": "The MIF Antagonist ISO-1 Attenuates Corticosteroid-Insensitive Inflammation and Airways Hyperresponsiveness in an Ozone-Induced Model of COPD.", "Pagination": {"StartPage": "e0146102", "MedlinePgn": "e0146102"}, "Abstract": {"AbstractText": ["Macrophage migration inhibitory factor (MIF) is an inflammatory cytokine associated with acute and chronic inflammatory disorders and corticosteroid insensitivity. Its expression in the airways of patients with chronic obstructive pulmonary disease (COPD), a relatively steroid insensitive inflammatory disease is unclear, however.", "Sputum, bronchoalveolar lavage (BAL) macrophages and serum were obtained from non-smokers, smokers and COPD patients. To mimic oxidative stress-induced COPD, mice were exposed to ozone for six-weeks and treated with ISO-1, a MIF inhibitor, and/or dexamethasone before each exposure. BAL fluid and lung tissue were collected after the final exposure. Airway hyperresponsiveness (AHR) and lung function were measured using whole body plethysmography. HIF-1\u03b1 binding to the Mif promoter was determined by Chromatin Immunoprecipitation assays.", "MIF levels in sputum and BAL macrophages from COPD patients were higher than those from non-smokers, with healthy smokers having intermediate levels. MIF expression correlated with that of HIF-1\u03b1 in all patients groups and in ozone-exposed mice. BAL cell counts, cytokine mRNA and protein expression in lungs and BAL, including MIF, were elevated in ozone-exposed mice and had increased AHR. Dexamethasone had no effect on these parameters in the mouse but ISO-1 attenuated cell recruitment, cytokine release and AHR.", "MIF and HIF-1\u03b1 levels are elevated in COPD BAL macrophages and inhibition of MIF function blocks corticosteroid-insensitive lung inflammation and AHR. Inhibition of MIF may provide a novel anti-inflammatory approach in COPD."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Airway Disease Section, National Heart & Lung Institute, NIHR Respiratory Biomedical Research Unit at the Royal Brompton NHS Foundation Trust and Imperial College London, London, United Kingdom."}], "LastName": "Russell", "ForeName": "Kirsty E", "Initials": "KE"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Airway Disease Section, National Heart & Lung Institute, NIHR Respiratory Biomedical Research Unit at the Royal Brompton NHS Foundation Trust and Imperial College London, London, United Kingdom."}], "LastName": "Chung", "ForeName": "Kian Fan", "Initials": "KF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Airway Disease Section, National Heart & Lung Institute, NIHR Respiratory Biomedical Research Unit at the Royal Brompton NHS Foundation Trust and Imperial College London, London, United Kingdom."}], "LastName": "Clarke", "ForeName": "Colin J", "Initials": "CJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Airway Disease Section, National Heart & Lung Institute, NIHR Respiratory Biomedical Research Unit at the Royal Brompton NHS Foundation Trust and Imperial College London, London, United Kingdom."}], "LastName": "Durham", "ForeName": "Andrew L", "Initials": "AL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Airway Disease Infection Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom."}], "LastName": "Mallia", "ForeName": "Patrick", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Airway Disease Infection Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom."}], "LastName": "Footitt", "ForeName": "Joseph", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Airway Disease Infection Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom."}], "LastName": "Johnston", "ForeName": "Sebastian L", "Initials": "SL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Airway Disease Section, National Heart & Lung Institute, NIHR Respiratory Biomedical Research Unit at the Royal Brompton NHS Foundation Trust and Imperial College London, London, United Kingdom."}], "LastName": "Barnes", "ForeName": "Peter J", "Initials": "PJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "RRI DPU, GlaxoSmithKline, Stevenage, United Kingdom."}], "LastName": "Hall", "ForeName": "Simon R", "Initials": "SR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "RRI DPU, GlaxoSmithKline, Stevenage, United Kingdom."}], "LastName": "Simpson", "ForeName": "Karen D", "Initials": "KD"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Priority Research Centre for Respiratory Diseases, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia."}], "LastName": "Starkey", "ForeName": "Malcolm R", "Initials": "MR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Priority Research Centre for Respiratory Diseases, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia."}], "LastName": "Hansbro", "ForeName": "Philip M", "Initials": "PM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Airway Disease Section, National Heart & Lung Institute, NIHR Respiratory Biomedical Research Unit at the Royal Brompton NHS Foundation Trust and Imperial College London, London, United Kingdom."}], "LastName": "Adcock", "ForeName": "Ian M", "Initials": "IM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Airway Disease Section, National Heart & Lung Institute, NIHR Respiratory Biomedical Research Unit at the Royal Brompton NHS Foundation Trust and Imperial College London, London, United Kingdom."}], "LastName": "Wiegman", "ForeName": "Coen H", "Initials": "CH"}], "GrantList": [{"Agency": "Wellcome Trust", "Country": "United Kingdom"}, {"GrantID": "G0600879", "Acronym": "MRC_", "Agency": "Medical Research Council", "Country": "United Kingdom"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "PLoS One", "NlmUniqueID": "101285081", "ISSNLinking": "1932-6203"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "3-(4-hydroxyphenyl)-4,5-dihydro-5-isoxazoleacetic acid methyl ester"}, {"RegistryNumber": "0", "NameOfSubstance": "Adrenal Cortex Hormones"}, {"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "0", "NameOfSubstance": "HIF1A protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypoxia-Inducible Factor 1, alpha Subunit"}, {"RegistryNumber": "0", "NameOfSubstance": "Isoxazoles"}, {"RegistryNumber": "0", "NameOfSubstance": "Macrophage Migration-Inhibitory Factors"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Messenger"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "7S5I7G3JQL", "NameOfSubstance": "Dexamethasone"}], "MeshHeadingList": [{"QualifierName": ["therapeutic use"], "DescriptorName": "Adrenal Cortex Hormones"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Bronchoalveolar Lavage Fluid"}, {"QualifierName": [], "DescriptorName": "Cell Count"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cytokines"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Dexamethasone"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Hypoxia-Inducible Factor 1, alpha Subunit"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Isoxazoles"}, {"QualifierName": ["pathology"], "DescriptorName": "Lung"}, {"QualifierName": ["antagonists & inhibitors", "genetics", "metabolism"], "DescriptorName": "Macrophage Migration-Inhibitory Factors"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Macrophages"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": [], "DescriptorName": "Ozone"}, {"QualifierName": ["complications", "genetics", "pathology", "physiopathology"], "DescriptorName": "Pneumonia"}, {"QualifierName": ["complications", "drug therapy", "genetics", "pathology"], "DescriptorName": "Pulmonary Disease, Chronic Obstructive"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "RNA, Messenger"}, {"QualifierName": [], "DescriptorName": "Respiratory Function Tests"}, {"QualifierName": ["complications", "drug therapy", "genetics", "physiopathology"], "DescriptorName": "Respiratory Hypersensitivity"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Smoking"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Sputum"}], "CoiStatement": "<b>Competing Interests: </b>SRH and KDS are employees of GSK. This study was funded in part by GSK and by the MRC-ABPI COPDMAP consortia. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Bloom BR, Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science. 1966;153(3731):80\u20132.", "ArticleIdList": ["5938421"]}, {"Citation": "David JR. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci U S A. 1966;56(1):72\u20137.", "ArticleIdList": ["PMC285677", "5229858"]}, {"Citation": "Calandra T, Echtenacher B, Roy DL, Pugin J, Metz CN, Hultner L, et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med. 2000;6(2):164\u201370.", "ArticleIdList": ["10655104"]}, {"Citation": "Leech M, Metz C, Hall P, Hutchinson P, Gianis K, Smith M, et al. Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis and rheumatism. 1999;42(8):1601\u20138.", "ArticleIdList": ["10446857"]}, {"Citation": "Rossi AG, Haslett C, Hirani N, Greening AP, Rahman I, Metz CN, et al. Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma. The Journal of Clinical Investigation. 1998;101(12):2869\u201374.", "ArticleIdList": ["PMC508878", "9637721"]}, {"Citation": "Mizue Y, Ghani S, Leng L, McDonald C, Kong P, Baugh J, et al. Role for macrophage migration inhibitory factor in asthma. Proceedings of the National Academy of Sciences of the United States of America. 2005;102(40):14410\u20135.", "ArticleIdList": ["PMC1242335", "16186482"]}, {"Citation": "She WB, Liu XS, Ni W, Chen SX, Xu YJ. The expression of macrophage migration inhibition factor in pulmonary tissues of smokers with or without chronic obstructive pulmonary disease. Zhonghua nei ke za zhi. 2012;51(11):863\u20136.", "ArticleIdList": ["23291023"]}, {"Citation": "GOLD. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). Available from2013."}, {"Citation": "Triantaphyllopoulos K, Hussain F, Pinart M, Zhang M, Li F, Adcock I, et al. A model of chronic inflammation and pulmonary emphysema after multiple ozone exposures in mice. American Journal of Physiology\u2014Lung Cellular and Molecular Physiology. 2011;300(5):L691\u2013L700. 10.1152/ajplung.00252.2010", "ArticleIdList": ["10.1152/ajplung.00252.2010", "PMC3094024", "21355040"]}, {"Citation": "Beckett EL, Stevens RL, Jarnicki AG, Kim RY, Hanish I, Hansbro NG, et al. A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis. Journal of Allergy and Clinical Immunology. 2013;131(3):752\u201362.e7. 10.1016/j.jaci.2012.11.053", "ArticleIdList": ["10.1016/j.jaci.2012.11.053", "PMC4060894", "23380220"]}, {"Citation": "D\u00e9ry M-AC, Michaud MD, Richard DE. Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. The international journal of biochemistry & cell biology. 2005;37(3):535\u201340.", "ArticleIdList": ["15618010"]}, {"Citation": "Semenza GL. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol (1985). 2000;88(4):1474\u201380.", "ArticleIdList": ["10749844"]}, {"Citation": "Lubetsky JB, Dios A, Han J, Aljabari B, Ruzsicska B, Mitchell R, et al. The Tautomerase Active Site of Macrophage Migration Inhibitory Factor Is a Potential Target for Discovery of Novel Anti-inflammatory Agents. Journal of Biological Chemistry. 2002;277(28):24976\u201382.", "ArticleIdList": ["11997397"]}, {"Citation": "Chen PF, Luo YL, Wang W, Wang JX, Lai WY, Hu SM, et al. ISO-1, a macrophage migration inhibitory factor antagonist, inhibits airway remodeling in a murine model of chronic asthma. Mol Med. 2010;16(9\u201310):400\u20138. 10.2119/molmed.2009.00128", "ArticleIdList": ["10.2119/molmed.2009.00128", "PMC2935952", "20485865"]}, {"Citation": "Mallia P, Footitt J, Sotero R, Jepson A, Contoli M, Trujillo-Torralbo MB, et al. Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(11):1117\u201324. 10.1164/rccm.201205-0806OC", "ArticleIdList": ["10.1164/rccm.201205-0806OC", "PMC3530206", "23024024"]}, {"Citation": "Mallia P, Message SD, Gielen V, Contoli M, Gray K, Kebadze T, et al. Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med. 2011;183(6):734\u201342. 10.1164/rccm.201006-0833OC", "ArticleIdList": ["10.1164/rccm.201006-0833OC", "PMC3081284", "20889904"]}, {"Citation": "Hansbro PM, Hamilton MJ, Fricker M, Gellatly SL, Jarnicki AG, Zheng D, et al. Importance of Mast Cell Prss31/Transmembrane Tryptase/Tryptase-\u03b3 in Lung Function and Experimental Chronic Obstructive Pulmonary Disease and Colitis. Journal of Biological Chemistry. 2014;289(26):18214\u201327. 10.1074/jbc.M114.548594", "ArticleIdList": ["10.1074/jbc.M114.548594", "PMC4140286", "24821729"]}, {"Citation": "Li F, Wiegman C, Seiffert JM, Zhu J, Clarke C, Chang Y, et al. Effects of N-acetylcysteine in ozone-induced chronic obstructive pulmonary disease model. PLoS ONE. 2013;8(11):e80782 10.1371/journal.pone.0080782", "ArticleIdList": ["10.1371/journal.pone.0080782", "PMC3832609", "24260479"]}, {"Citation": "Ito K, Ito M, Elliott WM, Cosio B, Caramori G, Kon OM, et al. D ecreased Histone Deacetylase Activity in Chronic Obstructive Pulmonary Disease. New England Journal of Medicine. 2005;352(19):1967\u201376.", "ArticleIdList": ["15888697"]}, {"Citation": "Wiegman CH, Li F, Clarke CJ, Jazrawi E, Kirkham P, Barnes PJ, et al. A comprehensive analysis of oxidative stress in the ozone-induced lung inflammation mouse model. Clinical science (London, England: 1979). 2013.", "ArticleIdList": ["24040961"]}, {"Citation": "Fallica J, Boyer L, Kim B, Serebreni L, Varela L, Hamdan O, et al. Macrophage Migration Inhibitory Factor (MIF) is a Novel Determinant of Cigarette Smoke-induced Lung Damage. American Journal of Respiratory Cell and Molecular Biology. 2014.", "ArticleIdList": ["PMC4091857", "24490973"]}, {"Citation": "Sauler M, Leng L, Trentalange M, Haslip M, Shan P, Piecychna M, et al. Macrophage Migration Inhibitory Factor Deficiency in Chronic Obstructive Pulmonary Disease. American journal of physiology Lung cellular and molecular physiology. 2014.", "ArticleIdList": ["PMC3949087", "24441872"]}, {"Citation": "Shaykhiev R1, Krause A, Salit J, Strulovici-Barel Y, Harvey BG, O'Connor TP, Crystal RG. Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease. J Immunol. 2009. August 15;183(4):2867\u201383. 10.4049/jimmunol.0900473", "ArticleIdList": ["10.4049/jimmunol.0900473", "PMC2873685", "19635926"]}, {"Citation": "Le Hiress M, Tu L, Ricard N, Phan C, Thuillet R, Fadel E, Dorfm\u00fcller P, Montani D, de Man F, Humbert M, Huertas A, Guignabert C. Pro-inflammatory Signature of the Dysfunctional Endothelium in Pulmonary Hypertension: Role of MIF/CD74 Complex Am J Respir Crit Care Med. 2015. July 23.", "ArticleIdList": ["26203495"]}, {"Citation": "Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature. 1995;377(6544):68\u201371.", "ArticleIdList": ["7659164"]}, {"Citation": "Leech M, Metz C, Santos L, Peng T, Holdsworth SR, Bucala R, et al. Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis. Arthritis and rheumatism. 1998;41(5):910\u20137.", "ArticleIdList": ["9588744"]}, {"Citation": "Al-Abed Y, Dabideen D, Aljabari B, Valster A, Messmer D, Ochani M, et al. ISO-1 Binding to the Tautomerase Active Site of MIF Inhibits Its Pro-inflammatory Activity and Increases Survival in Severe Sepsis. Journal of Biological Chemistry. 2005;280(44):36541\u20134.", "ArticleIdList": ["16115897"]}, {"Citation": "Kobayashi M, Nasuhara Y, Kamachi A, Tanino Y, Betsuyaku T, Yamaguchi E, et al. Role of macrophage migration inhibitory factor in ovalbumin-induced airway inflammation in rats. The European respiratory journal. 2006;27(4):726\u201334.", "ArticleIdList": ["16455830"]}, {"Citation": "Yoshihisa Y, Makino T, Matsunaga K, Honda A, Norisugi O, Abe R, et al. Macrophage Migration Inhibitory Factor Is Essential for Eosinophil Recruitment in Allergen-Induced Skin Inflammation. J Invest Dermatol. 2011;131(4):925\u201331. 10.1038/jid.2010.418", "ArticleIdList": ["10.1038/jid.2010.418", "21191413"]}, {"Citation": "Bozza M, Satoskar AR, Lin G, Lu B, Humbles AA, Gerard C, et al. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med. 1999;189(2):341\u20136.", "ArticleIdList": ["PMC2192995", "9892616"]}, {"Citation": "Hirano S. Migratory responses of PMN after intraperitoneal and intratracheal administration of lipopolysaccharide. The American journal of physiology. 1996;270(5 Pt 1):L836\u201345.", "ArticleIdList": ["8967519"]}, {"Citation": "Makita H, Nishimura M, Miyamoto K, Nakano T, Tanino Y, Hirokawa J, et al. Effect of Anti-Macrophage Migration Inhibitory Factor Antibody on Lipopolysaccharide-induced Pulmonary Neutrophil Accumulation. American Journal of Respiratory and Critical Care Medicine. 1998;158(2):573\u20139.", "ArticleIdList": ["9700137"]}, {"Citation": "Magalh\u00e3es ES, Mourao-Sa DS, Vieira-de-Abreu A, Figueiredo RT, Pires AL, Farias-Filho FA, et al. Macrophage migration inhibitory factor is essential for allergic asthma but not for Th2 differentiation. European Journal of Immunology. 2007;37(4):1097\u2013106.", "ArticleIdList": ["17373669"]}, {"Citation": "Korsgren M, #228, llstr m L, Uller L, et al. Role of macrophage migration inhibitory factor (MIF) in allergic and endotoxin-induced airway inflammation in mice. Mediators of Inflammation. 2000;9(1):15\u201323.", "ArticleIdList": ["PMC1781742", "10877450"]}, {"Citation": "Adcock IM, Barnes PJ. Molecular mechanisms of corticosteroid resistance*. Chest. 2008;134(2):394\u2013401. 10.1378/chest.08-0440", "ArticleIdList": ["10.1378/chest.08-0440", "18682458"]}, {"Citation": "Gaber T, Schellmann S, Erekul KB, Fangradt M, Tykwinska K, Hahne M, et al. Macrophage Migration Inhibitory Factor Counterregulates Dexamethasone-Mediated Suppression of Hypoxia-Inducible Factor-1\u03b1 Function and Differentially Influences Human CD4+ T Cell Proliferation under Hypoxia. The Journal of Immunology. 2011;186(2):764\u201374. 10.4049/jimmunol.0903421", "ArticleIdList": ["10.4049/jimmunol.0903421", "21169549"]}, {"Citation": "Baugh JA, Gantier M, Li L, Byrne A, Buckley A, Donnelly SC. Dual regulation of macrophage migration inhibitory factor (MIF) expression in hypoxia by CREB and HIF-1. Biochem Biophys Res Commun. 2006. September 8;347(4):895\u2013903.", "ArticleIdList": ["16854377"]}, {"Citation": "Mroz RM, Holownia A, Chyczewska E, Drost EM, Braszko JJ, Noparlik J, Donaldson K, Macnee W. Cytoplasm-nuclear trafficking of CREB and CREB phosphorylation at Ser133 during therapy of chronic obstructive pulmonary disease. J Physiol Pharmacol. 2007. November;58 Suppl 5(Pt 2):437\u201344.", "ArticleIdList": ["18204156"]}, {"Citation": "Di Stefano A, Caramori G, Ricciardolo FL, Capelli A, Adcock IM, Donner CF. Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview. Clin Exp Allergy. 2004. August;34(8):1156\u201367.", "ArticleIdList": ["15298554"]}, {"Citation": "Brown V, Elborn JS, Bradley J, Ennis M. Dysregulated apoptosis and NFkappaB expression in COPD subjects. Respir Res. 2009. March 18;10:24 10.1186/1465-9921-10-24", "ArticleIdList": ["10.1186/1465-9921-10-24", "PMC2667166", "19296848"]}], "ReferenceList": []}], "History": [{"Year": "2015", "Month": "7", "Day": "24"}, {"Year": "2015", "Month": "12", "Day": "14"}, {"Year": "2016", "Month": "1", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "1", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "7", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "1", "Day": "11"}], "PublicationStatus": "epublish", "ArticleIdList": ["26752192", "PMC4709227", "10.1371/journal.pone.0146102", "PONE-D-15-32395"]}}], "PubmedBookArticle": []}